RxDoctor Payments Data

Lucien Alexandre, MD

Interventional Pain Medicine · Hollywood, FLNPI 1104111012

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,540 of the $18,420 with a category attached, or 68.1%. It is spread thinly across 33 manufacturers, the largest accounting for just 22.4%. Reporting peaked in 2023 at $5,209 and has fallen 75.2% since, to $1,294 in 2025.

$18,420in general payments, 2019–2025

Across 390 payments — averaging $47.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Nalu Medical, Inc.$3K
  • Spinal Simplicity, LLC$2K
  • Genesys Orthopedics Systems, L.L.C.$2K
  • Nevro Corp.$2K
  • Relievant Medsystems, Inc.$752
  • plus $5K from 27 others

What the payments were for

  • Travel & lodging$4,33124%
  • Food & beverage$12,54068%
  • Education$1,5198%
  • Gifts$300%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,420 in reported general payments places this provider in the 85th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$272,318
Medicare patients
177
Services billed
2,356

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine23$5,436
Baclofen23$511
Gabapentin26$244
Tramadol Hcl39$236
Pregabalin25$234
Acetaminophen-CodeineAcetaminophen With Codeine26$208
Oxycodone Hcl13$171
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$131
Diclofenac Sodium11$51
Cephalexin17$32

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →